CBD Life Sciences, Inc. (CBDL) Set to Launch Products on Alibaba Platform

SCOTTSDALE, AZ / ACCESSWIRE / September 22, 2021 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. announces that the company is set to launch over 40 products on the Alibaba Platform with one product already available through this link provided. https://www.alibaba.com/product-detail/LBC-Hemp-Oil-Herbal-Drops-500mg_10000003855426.html?spm=a2747.manage.0.0.1fef2c3cPWZsnK.

CBD Life Sciences Inc. is excited to start blasting products onto the platform with over 40 different options! The products the company is working with to upload are Tinctures, Edibles, Skincare, Pet Products, CBD Cartridges, etc. President & CEO Lisa Nelson states “This is huge news for us, and we are going to start out with 41 products for now as we are rapidly growing, and this is only the beginning.” Lisa Nelson also states, “Multiple streams of revenue is the goal here and we are already off to a phenomenal start with Amazon & now Alibaba!” CBD Life Sciences Inc. is currently planning to add more products to Amazon along with getting on as many platforms as possible to push the products out the door and connect with multiple businesses around the world.

Alibaba is comfortably one of the most popular sites among the world’s largest Internet market. As of Q2 2014, the site boasted around 279 million annual active buyers, and it’s been suggested that by the year 2017, more than $700 billion of combined sales could be made through its various websites and marketplaces including Taobao, Tmall and Alipay. Alibaba also has a huge global appeal. You can find, buy from, and sell to companies and users in over 240 countries around the world. This gives you unprecedented scope to open global markets, however small your business. Can you imagine how much time and money you’d need to invest on overseas travel, promotion, and trade shows to open those markets up on your own? Overall, B2B e-commerce is the way to go in 2021 and CBD Life Sciences Inc. is ahead of the game by far.

B2B e-commerce refers to the exchange of goods and services between businesses via online platforms. While the use of digital channels has previously been limited to B2C companies, consumer brands, and retail transactions, there have also been major digital advances and unprecedented adoption of e-commerce solutions in the B2B landscape over the past few years. In 2019, the global B2B e-commerce gross merchandise volume (GMV) amounted to 12.2 trillion U.S. dollars, up from approximately 5.83 trillion U.S. dollars in 2013. This rapid growth of the global B2B e-commerce space not only mirrors the ongoing digitalization of commerce, but it also signals the systematic digital restructuring of the B2B market worldwide. Lastly, according to Forrester, U.S. business-to-business (B2B) ecommerce transactions are expected to reach $1.8 trillion by 2023. This would account for 17% of all B2B sales in the country.

CBD Life Sciences Inc. is getting close to its 3^rd retail location along with a recreational marijuana facility. This will be significant as far as expansion and revenue go and CBD Life Sciences Inc. will keep the public informed moving forward.

The number of benefits CBD has is tremendous! These benefits include help with behavioral/neurological complications such as ADD/ADHD, anxiety, autism, bipolar, OCD, PTSD, epilepsy, Parkinson’s, osteoporosis, and ALS. CBD can also benefit pain management that can stem from headaches/migraines, arthritis, cramps, spinal injuries, and fibromyalgia. CBD has been found to also have gastrointestinal benefits with gastro-disorders and complications such as anorexia, cachexia, Crohn’s, diabetes, and nausea. Physical complications/disorders such as muscular dystrophy and even immune system-based deficiencies and other complications such as cancer and hypertension even our bodies way and ability to maintain homeostasis have all been said to benefit from CBD.

LBC BIOSCIENCE INC. ONLINE STORE

LBC BIOSCIENCE’S Online Emporium

LBC Bioscience Inc. is well stocked already as it is with some very high-quality CBD offerings – all at very reasonable prices. Check out LBC Bioscience Inc’s newest product offerings including its: 100MG CBD Bath Bombs in a variety of scents, Delta 8 Gummies, 1500 MG Premium Berry Drops, and a variety of all-new Skincare products. Or shop our top selling products (based on order frequency) which include our CBD Pain Cream, CBD Oils and CBD Pet Treats.

Become a Distributor

• Large Selection of Products (over 50 items and growing)
• 100% USA Made Products “organic & kosher.”
• All Products are THC-FREE (they contain 0.00% THC)
• Weekly Deals (new deals every week)
• 25% off on all products using code “LBC25.”

LBC Bioscience Inc. accepts: Visa, MasterCard, American Express, Discover etc.

Shareholders and interest holders may also stay current with LBC Bioscience Inc Updates:

LBC Bioscience Inc’s Main Website at www.lbcbioscienceinc.com

Amazon: https://www.amazon.com/shops/lbcbioscienceinc

About LBC Bioscience Inc.
LBC Bioscience Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. LBC has developed and is retailing/wholesale a full line of cannabidiol based organic products including CBD Drops, Gumballs, Honey Sticks, Pain Relief Creams, Anxiety & Sleep Supplements, Edibles, Coffee, Skincare Line, Pet Line, Tablets and more. LBC’s products can be viewed and purchased on the Company’s website at www.lbcbioscienceinc.com.

Ten Associates LLC
Contact: Thomas E. Nelson
Telephone: (480) 326-8577
Email: [email protected]
Website: www.tenassociatesllc.com

Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc’s, Inc.’s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.

Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management’s current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.

SOURCE: CBD Life Sciences Inc.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.